- eFFECTOR Therapeutics Inc R&D Day TranscriptJan 24, 2024
- eFFECTOR Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- eFFECTOR Therapeutics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- eFFECTOR Therapeutics Inc Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Call TranscriptJan 05, 2023
- eFFECTOR Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- eFFECTOR Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- eFFECTOR Therapeutics Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- eFFECTOR Therapeutics Inc Update on Expanded Development of Zotatifin - Corporate Call TranscriptJun 05, 2022
- eFFECTOR Therapeutics Inc Provides Pipeline and Business Updates - Conference Call TranscriptJan 24, 2022
eFFECTOR Therapeutics Inc Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Call Transcript
Good afternoon and thank you for joining us today. Before we start, we encourage you to view the slides for this webcast as well as the press release issued this afternoon, both of which are accessible on our website in the Investors section.
During today's call, we will be making forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. Actual results could differ materially from those projected in these forward-looking statements due to risks and uncertainties associated with eFFECTOR 's business. These forward-looking statements are qualified by the cautionary statements contained in eFFECTOR 's SEC filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q and eFFECTOR 's press releases including today's release.
This call contains time-sensitive information that is accurate only as of the date of this live broadcast. eFFECTOR undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)